Jackson Taylor Therapeutics

📍 Wilmington, United States🗓 Founded 2023👥 2 employees
Biotechnology Research
LinkedIn
An AI/ML Genomics & Therapeutics R&D firm focused on mapping the Human Genome for Underserved Community Members to remove health disparities and commercializing therapeutics for equitable healthcare. We are sequencing the Human Genome for Undeserved Community Members ; developing/commercializing biologic drugs to treat diseases/viruses that significantly impact Underserved Community Members most; and providing a pathway to close the wealth gap within Underserved Communities by building a sustainable Informed Consent program that allows Research Participants to generate revenue from their genetic donations via both short-term/long-term U.S. Currency Payment Opportunities. Launched at Founder Institute - 2023 Toronto, Canada Cohort
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Jackson Taylor Therapeutics founded?
Jackson Taylor Therapeutics was founded in 2023.
What industry is Jackson Taylor Therapeutics in?
Jackson Taylor Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Jackson Taylor Therapeutics based?
Jackson Taylor Therapeutics is headquartered in Wilmington, United States.